LH Featured in Animal-Testing Alternatives Market Outlook Through 2035
What happened
A GlobeNewswire market research report covering the 2025–2035 animal testing and non-animal alternative testing landscape profiles Labcorp alongside Charles River Laboratories and Eurofins Scientific. The report examines the sector's structural shift toward alternative testing methodologies over the ten-year forecast window. Labcorp's inclusion signals its recognized position in preclinical and laboratory services as regulatory and commercial demand for non-animal testing methods expands across pharmaceutical and biotech end markets.
The QL Read
LH carries a composite signal of 65/100 against a constructive broad tape — 57.9% of issues advancing — yet shares are flat on the day at $335.72. Watch whether the sector tailwind narrative in this report is confirmed by the next LH contract-win or volume disclosure.